Restenosis after angioplasty: Have we found the holy grail?

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Statins: have we found the Holy Grail?

In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.

متن کامل

Selective allodepletion: have we finally found the holy grail?

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment option for patients with hematologic malignancies and nonmalignant disorders of hematopoiesis. Outcomes of allogeneic HSCT have improved steadily over the decades [1]. However, significant challenges remain. One of these challenges is the so-called Holy Grail of stem cell transplantation immunology: to...

متن کامل

Multidetector CT coronary angiography: have we found the holy grail of non-invasive coronary imaging?

Is technology about to deliver on the long awaited goal of effective non-invasive methods for visualising and assessing coronary arteries?

متن کامل

Sleeve gastrectomy: have we finally found the holy grail of bariatric surgery? A review of the literature.

OBJECTIVE Laparoscopic sleeve gastrectomy has become one of the most commonly performed bariatric operations. It is essentially a restrictive bariatric operation; however, a series of hormonal changes occurring postoperatively contribute to decreased appetite and reduced food intake. PATIENTS AND METHODS This is a literature review of recent articles published on Pubmed, Medline and Google Sc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Cardiology

سال: 2002

ISSN: 0160-9289,1932-8737

DOI: 10.1002/clc.4950250202